Results 31 to 40 of about 14,405,507 (294)

A skew t distribution

open access: yes, 2000
I first consider the formulation and properties of a new skew family of distributions on the real line which includes the (symmetric) Student t distributions as special cases.
Jones, M. C.
core   +5 more sources

A Comparison of the Risk Quantification in Traditional and Renewable Energy Markets

open access: yesEnergies, 2020
The transition from traditional energy to cleaner energy sources has raised concerns from companies and investors regarding, among other things, the impact on financial downside risk.
Daniel Velásquez-Gaviria   +2 more
doaj   +1 more source

Skewness-Kurtosis Model-Based Projection Pursuit with Application to Summarizing Gene Expression Data

open access: yesMathematics, 2021
Non-normality is a usual fact when dealing with gene expression data. Thus, flexible models are needed in order to account for the underlying asymmetry and heavy tails of multivariate gene expression measures.
Jorge M. Arevalillo, Hilario Navarro
doaj   +1 more source

Likelihood Based Inference and Bias Reduction in the Modified Skew-t-Normal Distribution

open access: yesMathematics, 2023
In this paper, likelihood-based inference and bias correction based on Firth’s approach are developed in the modified skew-t-normal (MStN) distribution.
Jaime Arrué   +4 more
doaj   +1 more source

Abatacept for Prophylaxis of Acute and Chronic Graft‐Versus‐Host‐Disease in Children Undergoing Allogeneic Hematopoietic Stem Cell Transplantation—A Systematic Review and Meta‐Analysis of Cohort Studies

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background Graft‐versus‐host disease (GvHD) remains one of the most significant complications of hematopoietic stem cell transplantation (HSCT). Abatacept, a selective T‐cell costimulation modulator, is a relatively novel prophylactic agent, though pediatric data remain limited.
Matthijs D. Kruizinga   +3 more
wiley   +1 more source

Robust Inferences from a Before-and-After Study with Multiple Unaffected Control Groups

open access: yesJournal of Causal Inference, 2013
The before-and-after study with multiple unaffected control groups is widely applied to study treatment effects. The current methods usually assume that the control groups’ differences between the before and after periods, i.e.
Wang Pengyuan   +2 more
doaj   +1 more source

Therapeutic Apheresis in Nigeria: A Multi‐Center Summary of Abstracts From the Inaugural Nigerian Society for Apheresis Scientific Meeting

open access: yesTherapeutic Apheresis and Dialysis, EarlyView.
ABSTRACT Background Therapeutic apheresis (TA) is an established treatment modality for hematologic, neurologic, and immunologic disorders, yet access remains severely limited in sub‐Saharan Africa. Donor apheresis, including platelet apheresis collection from healthy donors, represents an important complementary modality supporting blood product ...
Nosa Bazuaye   +33 more
wiley   +1 more source

The human gut microbiome across the life course

open access: yesFEBS Letters, EarlyView.
Despite significant individual variation and continuous change throughout life, the human gut microbiome follows some life stage‐specific trends. This article provides a brief overview of how gut microbiome composition shifts across different phases of life. Created in BioRender. Özkurt, E. (2026) https://BioRender.com/8q4nrnc.
Alise J. Ponsero   +4 more
wiley   +1 more source

Measuring risk based on skewed t distribution approach

open access: yesJournal of Physics: Conference Series, 2021
Abstract This paper analyses a Skewed t Distribution approach to estimate Value at Risk (VaR) as a tool that can measure a risk investment. The method can estimate an investment risk that can overcome the shortcoming of classical VaR, which cannot capture the existence of fat tail and skewness.
E Sulistianingsih   +2 more
openaire   +1 more source

Design and analysis strategies for robust microbiome ageing research

open access: yesFEBS Letters, EarlyView.
The gut microbiome changes with age and associates with age‐related morbidity and mortality, establishing it as a potential biomarker and intervention target for ageing. Realising this potential requires methodological rigour, yet distinguishing biological signals from methodological artefacts remains challenging across cohorts. This review provides an
Mark Olenik   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy